Research ArticleArticle
Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525
Denise Wootten
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (D.W., E.E.S., A.C., P.M.S.); Endocrine Discovery (K.W.S.) and Translational Science and Technologies (F.S.W.), Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; Centro de Investigación Lilly, Eli Lilly and Company, Alcobendas, Spain (A.B.B.)
Emilia E. Savage
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (D.W., E.E.S., A.C., P.M.S.); Endocrine Discovery (K.W.S.) and Translational Science and Technologies (F.S.W.), Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; Centro de Investigación Lilly, Eli Lilly and Company, Alcobendas, Spain (A.B.B.)
Francis S. Willard
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (D.W., E.E.S., A.C., P.M.S.); Endocrine Discovery (K.W.S.) and Translational Science and Technologies (F.S.W.), Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; Centro de Investigación Lilly, Eli Lilly and Company, Alcobendas, Spain (A.B.B.)
Ana B. Bueno
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (D.W., E.E.S., A.C., P.M.S.); Endocrine Discovery (K.W.S.) and Translational Science and Technologies (F.S.W.), Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; Centro de Investigación Lilly, Eli Lilly and Company, Alcobendas, Spain (A.B.B.)
Kyle W. Sloop
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (D.W., E.E.S., A.C., P.M.S.); Endocrine Discovery (K.W.S.) and Translational Science and Technologies (F.S.W.), Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; Centro de Investigación Lilly, Eli Lilly and Company, Alcobendas, Spain (A.B.B.)
Arthur Christopoulos
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (D.W., E.E.S., A.C., P.M.S.); Endocrine Discovery (K.W.S.) and Translational Science and Technologies (F.S.W.), Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; Centro de Investigación Lilly, Eli Lilly and Company, Alcobendas, Spain (A.B.B.)
Patrick M. Sexton
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (D.W., E.E.S., A.C., P.M.S.); Endocrine Discovery (K.W.S.) and Translational Science and Technologies (F.S.W.), Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; Centro de Investigación Lilly, Eli Lilly and Company, Alcobendas, Spain (A.B.B.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Differential Modulation of the GLP-1R
Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
Molecular Pharmacology April 1, 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement